HPV vaccine implementation and monitoring in Latin America
Objective. To describe HPV vaccine program implementation, monitoring and evaluation experiences in Latin America. Materials and methods. We reviewed published articles in peer-reviewed journals and reports from government websites, as well as the PAHO/WHO/UNICEF Joint Reporting form and the ICO/I...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Nacional de Salud Pública
2018-12-01
|
Series: | Salud Pública de México |
Subjects: | |
Online Access: | http://www.saludpublica.mx/index.php/spm/article/view/9090 |
id |
doaj-fa4f60c615e94dd8a295480358321747 |
---|---|
record_format |
Article |
spelling |
doaj-fa4f60c615e94dd8a2954803583217472020-11-25T00:59:03ZengInstituto Nacional de Salud PúblicaSalud Pública de México0036-36341606-79162018-12-01606, nov-dic68369210.21149/909016606HPV vaccine implementation and monitoring in Latin AmericaSilvana Luciani0Laia Bruni1Irene Agurto2Cuauhtémoc Ruiz-Matus3Unit of Noncommunicable Diseases, Department of Noncommunicable Diseases and Mental Health, Pan American Health OrganizationUnit of Infections and Cancer- Information and Interventions, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), IDIBELLUnit of Noncommunicable Diseases, Department of Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USAUnit of Comprehensive Family Immunization, Department of Family, Gender and Lifecourse, Pan American Health OrganizationObjective. To describe HPV vaccine program implementation, monitoring and evaluation experiences in Latin America. Materials and methods. We reviewed published articles in peer-reviewed journals and reports from government websites, as well as the PAHO/WHO/UNICEF Joint Reporting form and the ICO/IARC HPV Information Centre database. Results. By December 2016, 13 countries/territories in Latin America (56%) have introduced HPV vaccines. The majority have done so in the past three years, targeting 10- 12 year old girls with a two dose schedule, through school programs. Vaccine coverage ranges from 30 to 87%. Safety monitoring is well established, but monitoring vaccine impact is not, and data are not available. Conclusions. Although Latin America is the most advanced developing region with HPV vaccine introduction, systems for its monitoring are weak and there is a paucity of consistently available coverage data for this vaccine. Challenges remain to introduce HPV vaccines in several countries, to achieve high coverage, and to strengthen monitoring, evaluation and reporting.http://www.saludpublica.mx/index.php/spm/article/view/9090immunization programHPV vaccinecervical cancer/preventionmonitoring |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Silvana Luciani Laia Bruni Irene Agurto Cuauhtémoc Ruiz-Matus |
spellingShingle |
Silvana Luciani Laia Bruni Irene Agurto Cuauhtémoc Ruiz-Matus HPV vaccine implementation and monitoring in Latin America Salud Pública de México immunization program HPV vaccine cervical cancer/prevention monitoring |
author_facet |
Silvana Luciani Laia Bruni Irene Agurto Cuauhtémoc Ruiz-Matus |
author_sort |
Silvana Luciani |
title |
HPV vaccine implementation and monitoring in Latin America |
title_short |
HPV vaccine implementation and monitoring in Latin America |
title_full |
HPV vaccine implementation and monitoring in Latin America |
title_fullStr |
HPV vaccine implementation and monitoring in Latin America |
title_full_unstemmed |
HPV vaccine implementation and monitoring in Latin America |
title_sort |
hpv vaccine implementation and monitoring in latin america |
publisher |
Instituto Nacional de Salud Pública |
series |
Salud Pública de México |
issn |
0036-3634 1606-7916 |
publishDate |
2018-12-01 |
description |
Objective. To describe HPV vaccine program implementation, monitoring and evaluation experiences in Latin America. Materials and methods. We reviewed published articles in peer-reviewed journals and reports from government websites, as well as the PAHO/WHO/UNICEF Joint Reporting form and the ICO/IARC HPV Information Centre database. Results. By December 2016, 13 countries/territories in Latin America (56%) have introduced HPV vaccines. The majority have done so in the past three years, targeting 10- 12 year old girls with a two dose schedule, through school programs. Vaccine coverage ranges from 30 to 87%. Safety monitoring is well established, but monitoring vaccine impact is not, and data are not available. Conclusions. Although Latin America is the most advanced developing region with HPV vaccine introduction, systems for its monitoring are weak and there is a paucity of consistently available coverage data for this vaccine. Challenges remain to introduce HPV vaccines in several countries, to achieve high coverage, and to strengthen monitoring, evaluation and reporting. |
topic |
immunization program HPV vaccine cervical cancer/prevention monitoring |
url |
http://www.saludpublica.mx/index.php/spm/article/view/9090 |
work_keys_str_mv |
AT silvanaluciani hpvvaccineimplementationandmonitoringinlatinamerica AT laiabruni hpvvaccineimplementationandmonitoringinlatinamerica AT ireneagurto hpvvaccineimplementationandmonitoringinlatinamerica AT cuauhtemocruizmatus hpvvaccineimplementationandmonitoringinlatinamerica |
_version_ |
1725219083925848064 |